This information
collection request is approved as submitted, except that prior to
distribution, FDA will put the legally-required PRA burden
statement in the front of the guidance and the OMB number will be
displayed.
Inventory as of this Action
Requested
Previously Approved
09/30/2010
36 Months From Approved
900
0
0
900
0
0
0
0
0
A draft guidance titled Guidance for
Administrative Procedures for CLIA Categorization was released for
coment August 14,2000. The document describes procedures FDA will
use to assign the complexity category to a device and includes
information that manufacturers should send to FDA in cases where
the complexity categorization is determined separate from the
premarket submission.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.